Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07692217 · ClinicalTrials.gov registry record
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Not yet
- Registry status
- 60
- Enrollment target
NCT07692217: Clinical Trial study, sponsored by University of Texas Southwestern Medical Center.
NCT07692217 is a clinical trial that has not yet begun recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07692217 has not yet begun recruiting, sponsored by University of Texas Southwestern Medical Center.
- NOT YET RECRUITING
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes when receiving extended half-life factor VIII.
Primary Outcome
To determine and compare in vivo thrombin generation parameters; endogenous thrombin potential (ETP) and peak thrombin (PT) for patients on efanesoctocog alfa or emicizumab
Interventions
- DRUG Half-life factor VIII based replacement therapy
- DRUG Non-FVIII based replacement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07 |
| Est. Completion | 2033-05 |
What is known before NCT07692217 opens enrollment
NCT07692217 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Half-life factor VIII based replacement therapy is the first listed.
NCT07692217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07692217 about?
NCT07692217 is a clinical study titled "TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies". This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes...
What is the current status of trial NCT07692217?
This trial is currently not yet recruiting. The enrollment target is 60 participants. The study started on 2026-07. Estimated completion is 2033-05.
What interventions are being tested in trial NCT07692217?
The interventions under investigation include: Half-life factor VIII based replacement therapy (DRUG), Non-FVIII based replacement therapy (DRUG).
Who is sponsoring clinical trial NCT07692217?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia